DAVID GASKIN: Open Payments
NPI 1952340291 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,438 in 77 payments from 29 companies in 2025. Trend: 2023 $2,394 · 2024 $1,866 · 2025 $1,438
Food & beverage: $1,438
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $264 |
| Novo Nordisk Inc | 14 | $180 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| PFIZER INC. | 3 | $68 |
| Radius Health, Inc. | 2 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
Products named: UBRELVY, REXULTI, Wegovy, NURTEC ODT, LEQVIO, TRELEGY ELLIPTA, SPRAVATO, Ozempic.
Industry payments across GA — which companies pay providers there.
